The Font of Federal Power: Wickard v. Filburn and the Aggregation Principle

2017 ◽  
Vol 42 (1) ◽  
pp. 49-66 ◽  
Author(s):  
James B. Barnes
1979 ◽  
Vol 41 (03) ◽  
pp. 475-490 ◽  
Author(s):  
Chaoho Ouyang ◽  
Che-Ming Teng

SummaryThe minimal concentration of the platelet aggregation principle (Platelet Aggregoserpen- tin, PAS) necessary to induce platelet aggregation was 10 ng/ml, about one-hundredth of that of the crude venom. PAS induced the release of platelet factors 3 and 4 from platelets, but the released platelet factor 3 was easily inactivated by the anti-phospholipid effect of PAS. Pretreatment of platelets with neuraminidase potentiated PAS-induced platelet aggregation. PAS-induced platelet aggregation was independent on released ADP; it could occur in the ADP-removing systems, such as apyrase or a combination of phosphoenolpyruvate and pyruvate kinase. However, PAS-induced platelet aggregation could be inhibited by adenine nucleotides and adenosine.PAS-induced platelet aggregation was inhibited by some anti-inflammatory agents, antimalarial drugs, local anesthetics, antihistamine and smooth muscle relaxants. After deaggregation of PAS-treated platelets, thrombin and sodium arachidonate could further induce platelet aggregation, but ADP and second dose of PAS could not. It is concluded that PAS-induced platelet aggregation is due to prostaglandin synthesis. Recent literatures on the mechanism of platelet aggregation were surveyed and the actions of PAS were discussed.


1992 ◽  
Vol 55 (10) ◽  
pp. 1396-1401 ◽  
Author(s):  
Ting-Ting Jong ◽  
Hwey-Ching Hwang ◽  
Meei-Yueh Jean ◽  
Tian-Shung Wu ◽  
Che-Ming Teng

1997 ◽  
Vol 76 (3) ◽  
pp. 353-372 ◽  
Author(s):  
Yuri M. Ermoliev ◽  
Arkadii V. Kryazhimskii ◽  
Andrzej Ruszczyński

Sign in / Sign up

Export Citation Format

Share Document